{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:38:08Z","timestamp":1778218688999,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute Division of Cancer Control and Population Sciences Collaborative Research Award for Fellows in Training"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00520-025-09506-6","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:30:20Z","timestamp":1746466220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding cancer survivor cost communication experiences and preferences"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8312-7418","authenticated-orcid":false,"given":"Heather N.","family":"Platter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin C.","family":"Vanderpool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Davidoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet S.","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"14","key":"9506_CR1","doi-asserted-by":"publisher","first-page":"15424","DOI":"10.1002\/cam4.6133","volume":"12","author":"CP Williams","year":"2023","unstructured":"Williams CP, Platter HN, Davidoff AJ, Vanderpool RC, Pisu M, de Moor J (2023) \u201cIt\u2019s just not easy to understand\u201d: a mixed methods study of health insurance literacy and insurance plan decision-making in cancer survivors. Cancer Med 12(14):15424\u201315434. https:\/\/doi.org\/10.1002\/cam4.6133","journal-title":"Cancer Med"},{"issue":"3","key":"9506_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jnci\/djab211","volume":"114","author":"KR Yabroff","year":"2022","unstructured":"Yabroff KR, Shih YT, Bradley C (2022) Treating the whole patient with cancer: the critical importance of understanding and addressing the trajectory of medical financial hardship. J Natl Cancer Inst 114(3):335\u2013337. https:\/\/doi.org\/10.1093\/jnci\/djab211","journal-title":"J Natl Cancer Inst"},{"key":"9506_CR3","doi-asserted-by":"publisher","unstructured":"Altice CK, Banegas MP, Tucker\u2010Seeley RD, Yabroff KR (2016) Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 109(2): djw205. https:\/\/doi.org\/10.1093\/jnci\/djw205","DOI":"10.1093\/jnci\/djw205"},{"issue":"23","key":"9506_CR4","first-page":"505","volume":"63","author":"DU Ekwueme","year":"2014","unstructured":"Ekwueme DU, Yabroff KR, Guy GP Jr et al (2014) Medical costs and productivity losses of cancer survivors\u2013United States, 2008\u20132011. MMWR Morb Mortal Wkly Rep 63(23):505\u2013510","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"9506_CR5","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1002\/cncr.28262","volume":"119","author":"EE Kent","year":"2013","unstructured":"Kent EE, Forsythe LP, Yabroff KR et al (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710\u20133717. https:\/\/doi.org\/10.1002\/cncr.28262","journal-title":"Cancer"},{"issue":"2","key":"9506_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/1055-9965.EPI-19-0460","volume":"29","author":"S Han","year":"2020","unstructured":"Han S, Zhao J, Zheng Z et al (2020) Medical financial hardship intensity and financial sacrifice associated with cancer in the United States. Cancer Epidemiol Biomarkers Prev 29(2):308\u2013317. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0460","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"9506_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","volume":"34","author":"SD Ramsey","year":"2016","unstructured":"Ramsey SD, Bansal A, Fedorenko CR et al (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34(9):980\u2013986. https:\/\/doi.org\/10.1200\/JCO.2015.64.6620","journal-title":"J Clin Oncol"},{"key":"9506_CR8","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1007\/s00520-018-4201-6","volume":"26","author":"SY Kim","year":"2018","unstructured":"Kim SY, Shin DW, Park B et al (2018) Cancer cost communication: experiences and preferences of patients, caregivers, and oncologists\u2014a nationwide triad study. Supportive Care Cancer 26:3517\u20133526. https:\/\/doi.org\/10.1007\/s00520-018-4201-6","journal-title":"Supportive Care Cancer"},{"issue":"4","key":"9506_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1200\/JCO.19.01564","volume":"38","author":"KR Yabroff","year":"2020","unstructured":"Yabroff KR, Bradley C, Shih YT (2020) Understanding financial hardship among cancer survivors in the United States: strategies for prevention and mitigation. J Clin Oncol 38(4):292\u2013301. https:\/\/doi.org\/10.1200\/JCO.19.01564","journal-title":"J Clin Oncol"},{"issue":"6","key":"9506_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cncr.30423","volume":"123","author":"YT Shih","year":"2017","unstructured":"Shih YT, Chien C (2017) A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer 123(6):928\u2013939. https:\/\/doi.org\/10.1002\/cncr.30423","journal-title":"Cancer"},{"issue":"7","key":"9506_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.6004\/jnccn.2020.7538","volume":"18","author":"N Khera","year":"2020","unstructured":"Khera N, Sugalski J, Krause D et al (2020) Current practices for screening and management of financial distress at NCCN member institutions. J Natl Compr Canc Netw 18(7):825\u2013831. https:\/\/doi.org\/10.6004\/jnccn.2020.7538","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"9506_CR12","doi-asserted-by":"publisher","first-page":"e1839","DOI":"10.1200\/OP.22.00276","volume":"18","author":"SS Voleti","year":"2022","unstructured":"Voleti SS, Warsame R, Mead-Harvey C et al (2022) Assessing patient-reported financial hardship in patients with cancer in routine clinical care. JCO Oncology Pract 18(11):e1839\u2013e1853. https:\/\/doi.org\/10.1200\/OP.22.00276","journal-title":"JCO Oncology Pract"},{"key":"9506_CR13","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","volume":"27","author":"NJ Meropol","year":"2009","unstructured":"Meropol NJ, Schrag D, Smith TJ et al (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27:3868\u20133874. https:\/\/doi.org\/10.1200\/JCO.2009.23.1183","journal-title":"J Clin Oncol"},{"key":"9506_CR14","volume-title":"Delivering high-quality cancer care: charting a new course for a system in crisis","author":"Institute of Medicine","year":"2013","unstructured":"Institute of Medicine (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, Washington, DC"},{"key":"9506_CR15","unstructured":"President\u2019s Cancer Panel (2018) Promoting value, affordability, and innovation in cancer drug treatment: a report to the President of the United States from the President\u2019s Cancer Panel https:\/\/prescancerpanel.cancer.gov\/report\/drugvalue\/ Retrieved 27 August 2024"},{"issue":"13","key":"9506_CR16","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD (2016) Sample size in qualitative interview studies: guided by information power. J Qualitative health research 26(13):1753\u20131760","journal-title":"J Qualitative health research"},{"key":"9506_CR17","unstructured":"Vardell E. Health insurance literacy: how people understand and make health insurance purchase decisions. 2017"},{"key":"9506_CR18","unstructured":"Centers for Medicare & Medicaid Services. Ending surprise medical bills. Retrieved on 4\/15\/2025 from https:\/\/www.cms.gov\/nosurprises"},{"key":"9506_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12913-016-1353-2","volume":"16","author":"WG Hunter","year":"2016","unstructured":"Hunter WG, Hesson A, Davis JK et al (2016) Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates. BMC Health Serv 16:108. https:\/\/doi.org\/10.1186\/s12913-016-1353-2","journal-title":"BMC Health Serv"},{"key":"9506_CR20","doi-asserted-by":"publisher","unstructured":"Bullock AJ, Hofstatter EW, Yushak ML & Buss MK (2012) Understanding patients\u2019 attitudes toward communication about the cost of cancer care. J Oncol Pract 8(4). https:\/\/doi.org\/10.1200\/JOP.2011.000418.","DOI":"10.1200\/JOP.2011.000418"},{"issue":"9","key":"9506_CR21","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1200\/JOP.19.00726","volume":"16","author":"M Pisu","year":"2020","unstructured":"Pisu M, Banegas MP, Liang MI, Tuzzio L, Henrikson NB (2020) How, when, and with whom should cost of care conversations occur? Preferences of two distinct cancer survivor groups. JCO Oncol Pract 16(9):e912\u2013e921. https:\/\/doi.org\/10.1200\/JOP.19.00726","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"9506_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11764-022-01175-2","volume":"17","author":"JA Yeager","year":"2023","unstructured":"Yeager JA, Zahnd WE, Eberth JM et al (2023) Financial navigation staff perspectives on patients\u2019 financial burden of cancer care. J of Cancer Surviv 17(5):1461\u20131470. https:\/\/doi.org\/10.1007\/s11764-022-01175-2","journal-title":"J of Cancer Surviv"},{"issue":"3","key":"9506_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s13187-015-0956-3","volume":"32","author":"RC Vanderpool","year":"2018","unstructured":"Vanderpool RC, Nichols H, Hoffler EF, Swanberg JE (2018) Cancer and employment issues: perspectives from cancer patient navigators. J Cancer Edu 32(3):460\u2013466. https:\/\/doi.org\/10.1007\/s13187-015-0956-3","journal-title":"J Cancer Edu"},{"key":"9506_CR24","unstructured":"National Cancer Institute. NCI dictionary of cancer terms: financial navigator. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/financial-navigator Accessed 16 October 2024"},{"key":"9506_CR25","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/1055-9965.EPI-20-1853","volume":"30","author":"MJ Doherty","year":"2021","unstructured":"Doherty MJ, Thom B, Gany F (2021) Evidence of the feasibility and preliminary efficacy of oncology financial navigation: a scoping review. Cancer Epidemiol Biomarkers Prev 30:1778\u20131784. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1853","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"9506_CR26","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1200\/OP.22.00665","volume":"19","author":"J Edward","year":"2023","unstructured":"Edward J, McLouth LE, Rayens MK, Eisele LP, Davis TS, Hildebrandt G (2023) Coverage and cost-of-care links: addressing financial toxicity among patients with hematologic. JCO Oncology Practice 19(5):3695-e705. https:\/\/doi.org\/10.1200\/OP.22.00665","journal-title":"JCO Oncology Practice"},{"issue":"8","key":"9506_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.6004\/jnccn.2024.7030","volume":"22","author":"SB Wheeler","year":"2024","unstructured":"Wheeler SB, Manning ML, Gellin M et al (2024) Impact of a comprehensive financial navigation intervention to reduce cancer-related financial toxicity. J Natl Compr Canc Netw 22(8):557\u2013562. https:\/\/doi.org\/10.6004\/jnccn.2024.7030","journal-title":"J Natl Compr Canc Netw"},{"key":"9506_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.6004\/jnccn.2020.7581","volume":"18","author":"K Watabayashi","year":"2020","unstructured":"Watabayashi K, Steelquist J, Overstreet KA et al (2020) A pilot study of a comprehensive financial navigation program in patients with cancer and caregivers. J Natl Compr Canc Netw 18:1366\u20131373. https:\/\/doi.org\/10.6004\/jnccn.2020.7581","journal-title":"J Natl Compr Canc Netw"},{"key":"9506_CR29","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1200\/JOP.18.00270","volume":"15","author":"SM Kircher","year":"2019","unstructured":"Kircher SM, Yarber J, Rutsohn J et al (2019) Piloting a financial counseling intervention for patients with cancer receiving chemotherapy. J Oncol Pract 15:e202\u2013e210. https:\/\/doi.org\/10.1200\/JOP.18.00270","journal-title":"J Oncol Pract"},{"key":"9506_CR30","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1200\/JOP.2017.024927","volume":"14","author":"V Shankaran","year":"2018","unstructured":"Shankaran V, Leahy T, Steelquist J et al (2018) Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 14:e122\u2013e129. https:\/\/doi.org\/10.1200\/JOP.2017.024927","journal-title":"J Oncol Pract"},{"key":"9506_CR31","doi-asserted-by":"publisher","unstructured":"Altomare I, Irwin B, Zafar SY, Houck K, Maloney B, Greenup R, Peppercorn J (2016) Physician experience and attitudes toward addressing the cost of cancer care. J Oncol Pract 12(3):e281\u2013e288, 247\u2013288.\u00a0https:\/\/doi.org\/10.1200\/JOP.2015.007401.","DOI":"10.1200\/JOP.2015.007401"},{"key":"9506_CR32","first-page":"607","volume":"21","author":"SY Zafar","year":"2015","unstructured":"Zafar SY, Chino F, Ubel PA et al (2015) The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care 21:607\u2013615","journal-title":"Am J Manag Care"},{"key":"9506_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1200\/JOP.2014.001406","volume":"10","author":"CM Bestvina","year":"2014","unstructured":"Bestvina CM, Zullig LL, Rushing C et al (2014) Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 10:162\u2013167. https:\/\/doi.org\/10.1200\/JOP.2014.001406","journal-title":"J Oncol Pract"},{"key":"9506_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.urology.2012.08.027","volume":"80","author":"OS Jung","year":"2012","unstructured":"Jung OS, Guzzo T, Lee D et al (2012) Out-of-pocket expenses and treatment choice for men with prostate cancer. Urology 80:1252\u20131257. https:\/\/doi.org\/10.1016\/j.urology.2012.08.027","journal-title":"Urology"},{"issue":"10","key":"9506_CR35","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1634\/theoncologist.2015-0168","volume":"20","author":"BR Meisenberg","year":"2015","unstructured":"Meisenberg BR, Varner A, Ellis E, Ebner S et al (2015) Patient attitudes regarding the cost of illness in cancer care. Oncologist 20(10):1199\u2013204. https:\/\/doi.org\/10.1634\/theoncologist.2015-0168","journal-title":"Oncologist"},{"key":"9506_CR36","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1200\/JCO.2010.29.1625","volume":"28","author":"SR Berry","year":"2010","unstructured":"Berry SR, Bell CM, Ubel PA et al (2010) Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28:4149\u20134153","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09506-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:02:57Z","timestamp":1749492177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9506"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09506-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"450"}}